Current Status of Research on COVID-19 Patients With Concomitant Hyperglycemia and the Management Strategies of Hyperglycemia
- VernacularTitle:新型冠状病毒感染合并高血糖症患者的研究现状及对高血糖管理策略的探讨
- Author:
Juan XIA
1
;
Lijuan DU
;
Xueli XI
;
Zhuping XU
Author Information
- Keywords: COVID-19; Glucocorticoids; Hyperglycemia; Glycemic control; Review
- From: Journal of Sichuan University (Medical Sciences) 2024;55(1):230-235
- CountryChina
- Language:Chinese
- Abstract: The global pandemic of coronavirus disease 2019(COVID-19)poses a serious threat to human health,leading to a relatively high mortality in patients with severe or critical conditions in particular.Hyperglycemia is one of the high-risk factors for poor prognosis in these patients.Patients with COVID-19 are more likely to develop hyperglycemia,regardless of whether there is a previous history of diabetes mellitus.Glucocorticoid therapy is an important part of the anti-inflammatory regimen for COVID-19.However,the use of glucocorticoid significantly increases the occurrence of hyperglycemic events in COVID-19 patients,ultimately leading to poor prognosis.Timely monitoring of blood glucose and early intervention for hyperglycemia contribute to the improvement in the outcome of COVID-19 patients.In this paper,we comprehensively reviewed the potential mechanisms of COVID-19 and concomitant hyperglycemia.We reviewed the latest findings on the blood glucose management strategies for COVID-19 patients with concomitant hyperglycemia,aiming to optimize the management of hyperglycemia in COVID-19 patients and improve the outcome of the disease.
